Adoptive immunotherapy with liver allograft–derived lymphocytes induces anti-HCV activity after liver transplantation in humans and humanized mice
about
Strategies to reduce hepatitis C virus recurrence after liver transplantationHuman cytomegalovirus infection elicits new decidual natural killer cell effector functions.Ex vivo analysis of resident hepatic pro-inflammatory CD1d-reactive T cells and hepatocyte surface CD1d expression in hepatitis C.Post-liver transplant hepatitis C virus recurrence: an unresolved thorny problem.Contradictory immune response in post liver transplantation hepatitis B and C.NK cells, innate immunity and hepatitis C infection after liver transplantation.Clinically applicable magnetic-labeling of natural killer cells for MRI of transcatheter delivery to liver tumors: preclinical validation for clinical translation.CD52-Negative NK Cells Are Abundant in the Liver and Less Susceptible to Alemtuzumab Treatment.Prevention of hepatitis C recurrence after liver transplantation: An update.Interferon alpha treatment stimulates interferon gamma expression in type I NKT cells and enhances their antiviral effect against hepatitis C virus.Teaching new tricks to an old foe: murinizing hepatitis C virus.Impact of multiplicity of functional KIR-HLA compound genotypes on hepatocellular carcinoma.Hepatic irradiation persistently eliminates liver resident NK cells.
P2860
Q22305418-D95A1E29-F588-4F6A-9D43-69EEB097D8D0Q27335494-48E04EB4-B27A-43D7-8F0B-2AAA48A0EE7CQ33744649-A2B05392-97DF-4CC4-B2C0-6EEF36BF382DQ34093760-56C3638C-040E-4EE2-A607-9ADC8F51A5EAQ34152074-DFE899C1-45BC-40D4-AAE3-B195C4B5E600Q35019869-8A106599-CD61-4CA8-BA7A-DFB4A59349F2Q35903264-DE6E0829-861C-43D6-BE11-297A7B30EF6EQ36113098-C2237F58-C592-489F-BE32-EF114225DD61Q36220172-6582D736-3006-412C-A6D5-30D91A991AAAQ36295405-559C834E-6EA9-4902-BEE0-B17E821C3B17Q42365662-A1F685CB-7282-4CF7-9659-1025F35AD644Q43196226-771238B6-BCC6-4576-9485-72FEB2F1FBE4Q55399606-EEDC1C23-D0B2-40AB-B804-AA823BCEB1A1
P2860
Adoptive immunotherapy with liver allograft–derived lymphocytes induces anti-HCV activity after liver transplantation in humans and humanized mice
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Adoptive immunotherapy with li ...... n in humans and humanized mice
@ast
Adoptive immunotherapy with li ...... n in humans and humanized mice
@en
Adoptive immunotherapy with li ...... n in humans and humanized mice
@nl
type
label
Adoptive immunotherapy with li ...... n in humans and humanized mice
@ast
Adoptive immunotherapy with li ...... n in humans and humanized mice
@en
Adoptive immunotherapy with li ...... n in humans and humanized mice
@nl
prefLabel
Adoptive immunotherapy with li ...... n in humans and humanized mice
@ast
Adoptive immunotherapy with li ...... n in humans and humanized mice
@en
Adoptive immunotherapy with li ...... n in humans and humanized mice
@nl
P2093
P2860
P50
P3181
P356
P1476
Adoptive immunotherapy with li ...... n in humans and humanized mice
@en
P2093
Hideki Ohdan
Hirotaka Tashiro
Kazuaki Chayama
Kohei Ishiyama
Michio Imamura
Naoya Sakamoto
Nobuhiko Hiraga
Toshimasa Asahara
Yuka Igarashi
Yuka Tanaka
P2860
P304
P3181
P356
10.1172/JCI38374
P407
P577
2009-10-01T00:00:00Z